A landmark study published in March in The BMJ adds an interesting layer to that picture
With melanotan (and all other peptides you get on the gray market) you also have a major risk because of how youre getting them
Answer these four questions and your decision becomes clear
Experiencing symptoms of low glutathione can significantly impact your quality of life
VermaS,PoulterNR,BhattDL,BainSC,BuseJB,LeiterLA,etal.Effects of liraglutide on cardiovascular outcomes in patients with type 2 diabetes mellitus with or without history of myocardial infarction or stroke: Post hoc analy- sis from the leader trial.Circulation.2018;138:288494, .MannJFE,FonsecaV,MosenzonO,RazI,GoldmanB,IdornT,etal.Effects of liraglutide versus placebo on cardiovascular events in patients with type 2 dia- betes mellitus and chronic kidney disease: Results from the LEADER trial.Circulation.2018;138:290818, VermaS,BhattDL,BainSC,BuseJB,MannJFE,MarsoSP,etal.Effect of liraglutide on cardiovascular events in patients with type 2 diabetes mellitus and polyvascular disease.Circulation.2018;137:217983, Funding This work was supported by the Instituto de Salud Carlos III (PI19/01375) co-financed with FEDER programme fund

Meanwhile, many patients turned to resources like the side effect comparison between semaglutide and tirzepatide to weigh their options as they considered switching medications or sourcing alternatives